Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab in Chronic Inflammatory Myopathies
NCT00443222Phase 3Completed
- Sponsor
- Karolinska Institutet
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of infliximab in polymyositis (PM), dermatomyositis (DM), inclusion body myositis (IBM), sponsored by Karolinska Institutet. Status: completed.
02
Drugs
infliximab
03
Conditions
polymyositis (PM)dermatomyositis (DM)inclusion body myositis (IBM)
Beyond the preview
Go deeper on NCT00443222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00443222.